Company · CIK 1576885
Acumen Pharmaceuticals, Inc.
| CIK | 1576885 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | ABOS (Nasdaq) |
| First annual or quarterly report | 2021-08-16 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294649 | 2026-03-26 | 2026-04-01 | 2 | |
| 333-278280 | 2024-03-27 | 2025-11-13 | 3 | |
| 333-266004 | 2022-07-01 | 2023-07-20 | 5 | |
| 333-256945 | 2021-06-09 | 2021-07-02 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-01 | EFFECTDeclared effective | 333-294649 | 9999999995-26-001054 |
| 2026-03-26 | S-3Shelf registered | 333-294649 | 0001628280-26-021442 |
| 2025-11-13 | 424B5Shelf takedown | 333-278280 | 0001628280-25-051852 |
| 2024-04-24 | EFFECTDeclared effective | 333-278280 | 9999999995-24-001108 |
| 2024-03-27 | S-3Shelf registered | 333-278280 | 0001628280-24-013290 |
| 2023-07-20 | 424B5Shelf takedown | 333-266004 | 0001193125-23-190497 |
| 2023-07-17 | 424B5Shelf takedown | 333-266004 | 0001193125-23-188165 |
| 2023-04-27 | 424B5Shelf takedown | 333-266004 | 0001193125-23-120009 |
| 2022-07-08 | EFFECTDeclared effective | 333-266004 | 9999999995-22-002006 |
| 2022-07-01 | S-3Shelf registered | 333-266004 | 0001193125-22-187296 |
| 2021-07-02 | 424B4Final prospectus | 333-256945 | 0001193125-21-207605 |
| 2021-06-30 | EFFECTDeclared effective | 333-256945 | 9999999995-21-002605 |
| 2021-06-24 | S-1/AAmendment | 333-256945 | 0001193125-21-198037 |
| 2021-06-09 | S-1Registration filed | 333-256945 | 0001193125-21-186863 |
| 2021-04-12 | DRSDraft made public | 377-04647 | 0000950123-21-004463 |